本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

NRX Pharmaceuticals Inc.

2.08
+0.02991.46%
成交量:13.51萬
成交額:28.17萬
市值:3,518.29萬
市盈率:-0.88
高:2.14
開:2.10
低:2.05
收:2.05
資料載入中...
2021/10/13

重要事件披露

8-K - Current report
2021/09/13

SEC問詢函

CORRESP [Cover] - Correspondence
2021/09/10

重要事件披露

8-K - Current report
2021/09/03

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/08/24

重要事件披露

8-K - Current report
2021/08/20

重要事件披露

8-K - Current report
2021/08/19

重要事件披露

8-K - Current report
2021/08/16

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/07/29

員工持股計劃

S-8 - Securities to be offered to employees in employee benefit plans
2021/07/07

SEC問詢函

CORRESP [Cover] - Correspondence
2021/07/06

[修訂]招股説明書

S-1/A [Amend] - General form for registration of securities under the Securities Act of 1933
2021/06/25

招股説明書

S-1 - General form for registration of securities under the Securities Act of 1933
2021/06/04

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/06/03

超過5%披露

SC 13D - General statement of acquisition of beneficial ownership
2021/05/28

重要事件披露

8-K - Current report
2021/05/28

重要事件披露

8-K - Current report
2021/05/26

重要事件披露

8-K - Current report
2021/05/26

超過5%披露

SC 13D/A [Amend] - General statement of acquisition of beneficial ownership
2021/05/24

重要事件披露

8-K - Current report
2021/05/24

交易所摘牌聲明

25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities